Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Crown ElectroKinetics | CRKN | Mar 14, 2025 | 3.42 | 0.00 |
Crown Holdings | CCK | Mar 14, 2025 | 89.06 | +2.25 |
Crown LNG | CGBS | Mar 14, 2025 | 0.26 | +9.75 |
Cryo-Cell International | CCEL | Mar 14, 2025 | 6.52 | +0.49 |
CryoPort | CYRX | Mar 14, 2025 | 6.41 | +2.72 |
CS Disco | LAW | Mar 14, 2025 | 4.31 | +2.13 |
CSG Systems International | CSGS | Mar 14, 2025 | 60.67 | +1.98 |
CSP | CSPI | Mar 14, 2025 | 16.06 | +2.29 |
CSW Industrials | CSWI | Mar 14, 2025 | 291.01 | +2.55 |
CSX | CSX | Mar 14, 2025 | 30.01 | +3.02 |
CTO Realty Growth | CTO | Mar 14, 2025 | 18.59 | +2.93 |
CTO Realty Growth A Pref | CTO-A | Mar 14, 2025 | 21.60 | -1.82 |
CTRL Group | MCTR | Mar 14, 2025 | 7.77 | 0.00 |
CTS | CTS | Mar 14, 2025 | 42.45 | +2.41 |
CubeSmart | CUBE | Mar 14, 2025 | 41.67 | +2.31 |
Cue Biopharma | CUE | Mar 14, 2025 | 0.96 | -1.76 |
Cullen Frost Bankers B Pref | CFR-B | Mar 14, 2025 | 17.97 | +0.45 |
Cullen/Frost Bankers | CFR | Mar 14, 2025 | 122.62 | +2.29 |
Cullinan Therapeutics | CGEM | Mar 14, 2025 | 8.79 | -1.46 |
Culp | CULP | Mar 14, 2025 | 5.14 | +2.59 |
Cumberland Pharmaceuticals | CPIX | Mar 14, 2025 | 5.46 | -0.55 |
Cummins | CMI | Mar 14, 2025 | 321.70 | +2.81 |
Cumulus Media A | CMLS | Mar 14, 2025 | 0.46 | +9.79 |
Curbline Properties | CURB | Mar 14, 2025 | 23.36 | +0.52 |
Curevac N.V. | CVAC | Mar 14, 2025 | 3.01 | -0.66 |
CuriosityStream | CURI | Mar 14, 2025 | 2.67 | +6.15 |
Curis | CRIS | Mar 14, 2025 | 2.84 | 0.00 |
CURRENC Group | CURR | Mar 14, 2025 | 2.03 | -41.33 |
Curtiss-Wright | CW | Mar 14, 2025 | 322.66 | +2.71 |
Cushing Mlp & Infrastructure Total Return Fund | SRV | Mar 14, 2025 | 43.49 | +1.02 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.